Growth Hormone Secretagogues
Ipamorelin
Selective ghrelin receptor (GHS-R1a) agonist pentapeptide.
≥99.3%
from$27.00
CJC-1295 (with DAC)
Long-acting GHRH analogue with drug affinity complex.
5.0(1)Batch CJC-0824A · 99.08%
$49.00
Price per vial, excluding shipping. Free shipping over $200.00.
Size
In stock — ships today if ordered before 14:00
1
Dispatched same business day before 14:00
Cold-chain packed free of charge
All products are sold strictly as laboratory research chemicals. They are NOT for human or veterinary consumption, medical, diagnostic or household use. By purchasing you confirm you are a qualified researcher aged 21 or over.
Research context
CJC-1295 with DAC is a tetra-substituted GHRH(1-29) analogue bearing a maleimido propionic acid linker that forms a covalent bond with serum albumin. The resulting extended half-life makes it a common tool compound in somatotropic axis and pituitary cell culture research.
CJC-1295 With DAC Research Peptide
Shop CJC-1295 with DAC for laboratory and analytical research requiring a synthetic growth hormone-releasing hormone analog. Buy CJC-1295 with DAC from a research-focused supplier that provides clear product specifications and quality information. Researchers can order CJC-1295 with DAC online for controlled laboratory, biochemical, and preclinical investigations where consistent peptide identity and handling are important. CJC-1295 with DAC is a synthetic peptide analog of growth hormone-releasing hormone. The DAC modification, commonly referred to as Drug Affinity Complex, is designed to alter the peptide’s pharmacokinetic characteristics compared with shorter-acting research analogs. This makes CJC-1295 with DAC relevant to laboratory studies investigating peptide signaling, receptor interactions, endocrine pathways, and growth hormone-related biological mechanisms.
Studied in
- GHRH receptor binding assays
- Pituitary somatotroph cell culture
- Peptide half-life extension research
Questions about this product
CJC-1295 is a synthetic analog of human growth hormone-releasing hormone (GHRH). It was developed to produce longer-lasting biological activity than native GHRH and has been investigated in both preclinical and human studies.
Related compounds
